Trialbee CEO Matt Walz explores the current impact of AI in delivering practical gains in clinical development and reflects on its future potential, where enrollment predictability may be the biggest prize of all.
News|Articles|July 20, 2026
A Guide to Patient Engagement & Recruitment (PER) Solutions
Author(s)Citeline
Advertisement
Buyer’s Guide: A Guide to Patient Engagement
& Recruitment (PER) Solutions
A well-constructed PER solution facilitates dialogue, awareness, community, trust, and participation. Learn the benefits of, the features to look for, and the questions to ask about PER solutions.
Advertisement
Related to this article
A biomarker test now decides who enters a precision medicine trial, yet results often go unused and assays are not ready when screening opens.
Hierarchical composite endpoints analyzed through pairwise comparisons more accurately reflect multifaceted treatment benefit than time-to-first-event composites, but transparent outcome prioritization, patient involvement in ranking, and reporting of Net Treatment Benefit remain underutilized despite their importance to interpretation.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
IgniteData and RealTime Partner to Streamline Clinical Data Transfer From eSource to Sponsor Systems
2
The Biggest Remaining Barriers to High-Quality RWE Across Oncology Data Platforms
3
ACT Brief: Design Drivers of Trial Representation, eSource-to-EDC Data Automation, and Roche's ALK7 Obesity License
4
Flexible Clinical Operations and Site Management Across a Diversified Biotech Portfolio: An Application of Quality by Design and Risk-Based Oversight
5